Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lessened its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 92.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 46,527 shares of the biopharmaceutical company’s stock after selling 556,772 shares during the period. […]